July 15National LMS Awareness Day
Explore our comprehensive annual accountability reports that detail our research funding commitments, grant awards, patient support initiatives, and community impact. Each report provides transparent insights into how we're advancing leiomyosarcoma (LMS) research and supporting patients and their families.
The National Leiomyosarcoma Foundation is committed to full transparency in our operations, funding decisions, and impact measurement.
Detailed breakdowns of our funding allocations, research investments, and operational expenses.
Comprehensive reporting on funded research projects, outcomes, and scientific breakthroughs.
Detailed accounts of patient support programs, educational initiatives, and community outreach efforts.
Reports on collaborations with healthcare institutions, research organizations, and community partners.
Access our comprehensive annual reports documenting our progress, achievements, and financial stewardship.
Full report to the LMS-sarcoma community — 2025 research awardees, Berlin Roundtable, Count Me In evaluation funding, and 2026 initiatives.
25th anniversary report covering research funding, grant awards, repurposed drug initiatives, and international collaborations.
Year in review covering LMS research, patient support programs, and community advocacy initiatives.
We're committed to transparency and welcome your questions about our accountability reports.
